Mechanisms of neisserial serum resistance.

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62

Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev (2004) 3.11

Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41

The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest (2001) 2.04

The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev (2004) 1.93

Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87

Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc Natl Acad Sci U S A (2003) 1.75

Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70

Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species. Infect Immun (2002) 1.55

The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun (2002) 1.45

Available carbon source influences the resistance of Neisseria meningitidis against complement. J Exp Med (2005) 1.30

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med (2008) 1.30

Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun (2007) 1.28

Questions about the behaviour of bacterial pathogens in vivo. Philos Trans R Soc Lond B Biol Sci (2000) 1.22

Transcriptome analysis of Neisseria meningitidis during infection. J Bacteriol (2003) 1.22

Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein A. Lab Invest (2009) 1.15

Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases. Mol Microbiol (2007) 1.13

Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog (2010) 1.11

Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl). J Clin Microbiol (2004) 1.10

An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol (2010) 1.07

Expression of AniA, the major anaerobically induced outer membrane protein of Neisseria gonorrhoeae, provides protection against killing by normal human sera. Infect Immun (2000) 1.06

Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage. PLoS One (2011) 1.03

The msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane. Infect Immun (2003) 1.01

Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae. Infect Immun (2006) 0.99

Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. Infect Immun (2008) 0.99

Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect Immun (2002) 0.96

Factor H and neisserial pathogenesis. Vaccine (2008) 0.96

The Pathobiology of Neisseria gonorrhoeae Lower Female Genital Tract Infection. Front Microbiol (2011) 0.93

Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun (2001) 0.91

Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity. Infect Immun (2002) 0.91

Effect of host lactate on gonococci and meningococci: new concepts on the role of metabolites in pathogenicity. Infect Immun (2007) 0.90

Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity. J Bacteriol (2001) 0.87

Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi. Infect Immun (2004) 0.86

Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst. Mol Microbiol (2011) 0.85

Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein. PLoS Pathog (2013) 0.85

Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infect Immun (2001) 0.84

Neisseria meningitidis has two independent modes of recognizing its human receptor CEACAM1. PLoS One (2011) 0.84

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. J Clin Microbiol (2015) 0.84

Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discovery. PLoS One (2012) 0.83

Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba. J Clin Microbiol (2009) 0.83

Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice. Infect Immun (2006) 0.82

Abrogation of neuraminidase reduces biofilm formation, capsule biosynthesis, and virulence of Porphyromonas gingivalis. Infect Immun (2011) 0.82

Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant. PLoS One (2015) 0.80

Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides. Clin Vaccine Immunol (2015) 0.79

Multiple Functions of Glutamate Uptake via Meningococcal GltT-GltM L-Glutamate ABC Transporter in Neisseria meningitidis Internalization into Human Brain Microvascular Endothelial Cells. Infect Immun (2015) 0.76

Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015. PLoS One (2016) 0.75

Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J (1996) 2.80

Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect (1997) 2.67

NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci U S A (1985) 2.49

Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol (1996) 2.30

Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis (1999) 2.04

Intuitive hypertext-based molecular identification of micro-organisms. Lancet (1999) 2.01

The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology (1999) 1.97

Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97

Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol (1993) 1.91

Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol (1994) 1.82

Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol (1998) 1.80

Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules. Mol Gen Genet (1997) 1.68

Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J Clin Microbiol (2001) 1.66

Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol (1994) 1.66

Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol (1999) 1.65

Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64

siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett (1998) 1.61

Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med Microbiol Immunol (1996) 1.46

Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans. Mol Cell Biol (2000) 1.43

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol (2000) 1.43

Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine (2001) 1.42

Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol (2000) 1.41

Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics (1991) 1.41

Staphylococcus aureus in urine and false-positive immunoassay for Chlamydia. Lancet (1992) 1.39

Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol (1991) 1.38

Rapid serogroup switching in Neisseria meningitidis. N Engl J Med (2000) 1.38

The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol Microbiol (1993) 1.37

An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg (1999) 1.36

Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35

Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31

Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis. J Bacteriol (2000) 1.26

Molecular characterization of eukaryotic polysialyltransferase-1. Nature (1995) 1.25

Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect Immun (1999) 1.24

Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid. Biochemistry (1995) 1.24

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23

Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol (1999) 1.22

Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains. J Bacteriol (1996) 1.21

Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers. J Clin Microbiol (2001) 1.21

Genetic isolation of meningococci of the electrophoretic type 37 complex. J Bacteriol (2001) 1.19

Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology (1995) 1.18

Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol (1998) 1.18

Systemic infection of an immunocompromised patient with Methylobacterium zatmanii. J Clin Microbiol (1999) 1.17

Cloning and functional characterization of a 30 kb gene locus required for lipopolysaccharide biosynthesis in Legionella pneumophila. Int J Med Microbiol (2000) 1.16

The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis (1996) 1.16

Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci. Med Microbiol Immunol (1997) 1.15

Molecular cloning and functional expression of bacteriophage PK1E-encoded endoneuraminidase Endo NE. Mol Microbiol (1995) 1.13

Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13

Cloning and expression of a cDNA encoding an elongation factor 1beta/delta protein from Echinococcus granulosus with immunogenic activity. Parasite Immunol (1999) 1.11

Chromosomal insertion and excision of a 30 kb unstable genetic element is responsible for phase variation of lipopolysaccharide and other virulence determinants in Legionella pneumophila. Mol Microbiol (2001) 1.09

Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci. Clin Diagn Lab Immunol (1999) 1.09

Sequence heterogeneity of the echinococcal antigen B. Mol Biochem Parasitol (1994) 1.08

Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 1.07

The central, surface-exposed region of the flagellar hook protein FlgE of Campylobacter jejuni shows hypervariability among strains. J Bacteriol (1998) 1.07

Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. J Antimicrob Chemother (2001) 1.04

Sequence and functional analysis of the cloned Neisseria meningitidis CMP-NeuNAc synthetase. FEMS Microbiol Lett (1992) 1.02

Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigens. J Clin Microbiol (1993) 1.01

A GAS-like gene family in the pathogenic fungus Candida glabrata. Microbiology (2001) 1.01

Autocatalytic polysialylation of polysialyltransferase-1. EMBO J (1996) 1.01

Molecular differentiation of dermatophyte fungi. Mycoses (1999) 1.01

Steal syndrome after kidney transplantation caused by A-V fistula at the thigh. Child Nephrol Urol (1989) 1.01

Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis. Infect Immun (1996) 0.99

mRNA trans-splicing in the human parasitic cestode Echinococcus multilocularis. J Biol Chem (2000) 0.99

Real-time impedance analysis of host cell response to meningococcal infection. J Microbiol Methods (2010) 0.99

Paramyosin of Echinococcus granulosus: cDNA sequence and characterization of a tegumental antigen. Parasitol Res (1993) 0.99

Detection of Staphylococcus aureus and Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in situ hybridization. J Clin Microbiol (1999) 0.98

A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol (2000) 0.98

Analysis of transcriptional control mechanisms of capsule expression in Neisseria meningitidis. Int J Med Microbiol (2001) 0.97

Identification of a hotspot for transformation of Neisseria meningitidis by shuttle mutagenesis using signature-tagged transposons. Mol Gen Genet (1998) 0.97

Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila. J Exp Med (1998) 0.96

Isolation of Brucella melitensis from a patient with hearing loss. Eur J Clin Microbiol Infect Dis (2006) 0.96

Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis. Infect Immun (1999) 0.96

Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin Exp Rheumatol (2004) 0.95

Comparative evaluation of a new Vitek 2 system for identification and antimicrobial susceptibility testing of Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (2006) 0.94

Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996. J Antimicrob Chemother (1998) 0.94

Cloning and characterization of beta-tubulin genes from Echinococcus multilocularis. Mol Biochem Parasitol (2000) 0.93

Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia. Eur J Pediatr (2001) 0.93

The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Brain Res Mol Brain Res (1999) 0.92

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol (2006) 0.92

Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis (2010) 0.92

Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis (2004) 0.91

In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother (1998) 0.91

Antibodies to the capsular polysaccharide of Neisseria meningitidis group B or E. coli K1 bind to the brains of infant rats in vitro but not in vivo. Microb Pathog (1986) 0.91

Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun (2001) 0.91

Identification of a cDNA clone from the larval stage of Echinococcus granulosus with homologies to the E. multilocularis antigen EM10-expressing cDNA clone. Parasitol Res (1994) 0.91

Genes associated with meningococcal capsule complex are also found in Neisseria gonorrhoeae. J Bacteriol (1996) 0.90

Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis. Epidemiol Infect (2000) 0.90

Cloning and sequencing of the genes coding for the 10- and 60-kDa heat shock proteins from Pseudomonas aeruginosa and mapping of a species-specific epitope. Infect Immun (1991) 0.90

Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. J Clin Microbiol (1997) 0.90

Characterization of the genomic locus expressing the ERM-like protein of Echinococcus multilocularis. Mol Biochem Parasitol (1999) 0.89

Development of an amplification and hybridization assay for the specific and sensitive detection of Mycoplasma fermentans DNA. Mol Cell Probes (1996) 0.89

Complete nucleotide and deduced protein sequence of CMP-NeuAc: poly-alpha-2,8 sialosyl sialyltransferase of Escherichia coli K1. Glycobiology (1991) 0.89

Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis (2003) 0.88

The identification of cryptic rhamnose biosynthesis genes in Neisseria gonorrhoeae and their relationship to lipopolysaccharide biosynthesis. J Bacteriol (1994) 0.86

Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med (2001) 0.85

Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. Neurobiol Aging (2001) 0.85

Immunohistochemical localization of polysialic acid in tissue sections: differential binding to polynucleotides and DNA of a murine IgG and a human IgM monoclonal antibody. J Histochem Cytochem (1990) 0.85

Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium. Microb Pathog (1997) 0.85

Molecular cloning and characterization of an Echinococcus multilocularis and Echinococcus granulosus stress protein homologous to the mammalian 78 kDa glucose regulated protein. Mol Biochem Parasitol (1995) 0.85

Sequence and expression in Escherichia coli of a Mycoplasma hominis gene encoding elongation factor Tu. Gene (1991) 0.84